U.S. Markets closed

Gilead shares up after FDA approves breakthrough cancer treatment

The FDA has approved a new cancer treatment developed by Gilead's $11B acquisition Kite Pharma. Yahoo Finance’s Alexis Christoforous, Rick Newman, and Nicole Sinclair have more.